Cytarabine
Links shared publicly online about this topic
Oncology Article | Leukemia, Myeloid, Acute Cytarabine
mdlinx.com — “Cytarabine dose for acute myeloid leukemia” View full resource at mdlinx.com
Most Recently Shared on March 18, 2011 at 5:51 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cytarabine dose for acute myeloid leukemia: New England Journal of Medicine http://bit.ly/g3vVOa #oncology
Oncology Article | Leukemia, Myeloid, Acute Cytarabine
mdlinx.com — “Cytarabine dose of 36 g/m2 compared with 12 g/m2 within first consolidation in acute myeloid leukemia: Results of patients enrolled onto the Prospective Randomized AMl96 Study” View full resource at mdlinx.com
Most Recently Shared on May 27, 2011 at 6:16 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cytarabine dose of 36 g/m2 compared with 12 g/m2 within first consolidation in acute myeloid leukemia:... http://bit.ly/kwzgGO #oncology
Update on the Chemo Drug Shortage: Cytarabine - WEGO Health
community.wegohealth.com — “A Cancer Patient's Worst Nightmare! As if cancer wasn't bad enough, try thinking aboutdealing with cancer without a critical component in your chemotherapy r--” View full resource at community.wegohealth.com
Most Recently Shared on April 20, 2011 at 1:38 am By:
Alicia C. Staley Patient Expert and Health Social Media
Checking out "Update on the Chemo Drug Shortage: Cytarabine" on WEGO Health: http://ning.it/eXeWsq
Cytarabine Crisis: Leukemia Drug Shortage Affecting Many Hospitals - ABC News
abcnews.go.com — “ABC News heard from dozens of medical centers on reported shortages of the leukemia drug cytarabine. While some hospitals reported no shortages, others said supplies of the drug were running critically low -- and in some places, shortages have even affected patient care.” View full resource at abcnews.go.com
Most Recently Shared on April 14, 2011 at 11:02 pm By:
Hisham Rana, MD Doctor and Physician
News: Cytarabine Crisis: Leukemia drug shortage affecting many U.S. hospitals http://abcn.ws/hHPh0t - #health #pharma
Oncology Medical Article | RNAi screening of the kinome with cytarabine in leukemias
mdlinx.com — “Oncology Medical Article: RNAi screening of the kinome with cytarabine in leukemias” View full resource at mdlinx.com
Most Recently Shared on January 27, 2012 at 2:06 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
RNAi screening of the kinome with cytarabine in leukemias: Blood http://t.co/GeeXUprW #oncology
Oncology Medical Article | Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients
mdlinx.com — “Oncology Medical Article: Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients” View full resource at mdlinx.com
Most Recently Shared on March 13, 2012 at 6:48 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with... http://t.co/JUscp55W #oncology
Multivariate Analysis of Response and Survival After Treatment With Clofarabine, Cytarabine, and G-CSF Priming (GCLAC) in Relapsed/Refractory Acute Myeloid Leukemia: Comparison With Prior Experience Using Fludarabine and Cytarabine Combination Regimens -
oncologynurseadvisor.com — “Pamela S. Becker, MD, PhD, at University of Washington in Seattle, Wash., and colleagues conducted a study that indicated priming with clofarabine, cytarabine, and granulocyte colony-stimulating factor (G-CSF) (GCLAC) is active in relapsed and refractory acute myeloid leukemia (AML). Results of this study were presented at the 52nd American Society of Hematology Meeting and Exposition.” View full resource at oncologynurseadvisor.com
Most Recently Shared on December 5, 2010 at 4:32 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Multivariate Analysis of Response and Survival After Treatment With Clofarabine, Cytarabine… http://goo.gl/fb/vRLof
Cytarabine Improves Results of High-dose Methotrexate in Patients with Primary CNS Lymphoma
professional.cancerconsultants.com — “Cytarabine Improves Results of High-dose Methotrexate in Patients with Primary CNS Lymphoma” View full resource at professional.cancerconsultants.com
Most Recently Shared on October 11, 2009 at 3:47 pm By:
CNS #Lymphoma - Cytarabine improves results of high-dose Methotrexate. http://bit.ly/VsEOB
Oncology News & Articles - MDLinx - Cisplatin Cytarabine Lymphoma Lymphoma, T-Cell on #MDlinx
mdlinx.com — “Oncology News & Articles - MDLinx - Cisplatin Cytarabine Lymphoma Lymphoma, T-Cell on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 26, 2010 at 9:52 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients... http://bit.ly/9VCcAR #oncology
Leukemia drug cytarabine is just one of many in short supply | cleveland.com
cleveland.com — “"It's scary to hear that the drug Erin depends on for her full recovery might not be there when we need it," Kevin Potter said while sitting at his daughter's bedside in Cleveland's Rainbow Babies and Children's Hospital.” View full resource at cleveland.com
Most Recently Shared on April 19, 2011 at 8:45 pm By:
RT @PDHealth: Leukemia drug cytarabine is just one of many in short supply http://bit.ly/i6SaoQ
Prevention of cytarabine-induced kerato-conjunctiv... [Int J Hematol. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on August 22, 2011 at 2:42 am By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Prevention of cytarabine-induced kerato-conjunctivitis by eye rinse in patients receivi... http://t.co/lvP1IKK #familyhealth
Secondary AML Patients Show No Increased Benefit by Adding Amonafide Instead of Daunorubicin in Cytarabine-Based Therapy - MPR
empr.com — “The combination of amonafide + cytarabine does not provide a complete response benefit over treatment with daunorubicin + cytarabine in patients with secondary acute myeloid leukemia, according to a presentation at the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at empr.com
Most Recently Shared on June 3, 2011 at 9:34 pm By:
MPR News: Secondary AML Patients Show No Increased Benefit by Adding Amonafide Instead of Daunorubicin in Cytara... http://bit.ly/lMFLoM
Comparison of high-dose cytarabine and timed-sequentia... [Blood. 2011] - PubMed - NCBI
ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on August 27, 2011 at 10:07 pm By:
G Garcia-Manero Internist, Oncologist, Physician, and Doctor
French study shows no difference between high dose ara-C consolidation and a time sequential approach. Trends... http://t.co/hGOZSih
Drug May Improve Outcomes for CNS Lymphomas - Study finds cytarabine addition to methotrexate improves remission rates - ModernMedicine
modernmedicine.com — “The addition of high-dose cytarabine to standard methotrexate treatment of primary central nervous system lymphomas greatly improves remission rates, according to a study published early online Sept. 20 in The Lancet to coincide with the European Cancer Organisation meeting in Berlin.” View full resource at modernmedicine.com
Most Recently Shared on September 22, 2009 at 1:38 am By:
Study shows high-dose Cytarabine to standard treatment greatly improves CNS Lymphoma remission rates. http://bit.ly/wN0O9
Sunesis Announces Publication of Nonclinical Data Demonstrating Activity of Vosaroxin Alone and in Combination With Cytarabine in Patients' Acute Myeloid Leukemia Blasts (Nasdaq:SNSS)
globenewswire.com — “Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced the publication of new nonclinical data by a leading academic group on the Company's lead drug candidate, vosaroxin, in the March 2011 issue of Haematologica. The results show vosaroxin's potent cytotoxic activity in primary patient AML blasts ex vivo when used alone and synergistic activity when used in combination with cytarabine, the current treatment standard in AML, consistent with prior observations in preclinical models. The stud” View full resource at globenewswire.com
Most Recently Shared on May 6, 2011 at 3:23 am By:
Sunesis Announces Publication of Nonclinical Data Demonstrating Activity of Vosaroxin Alone and in Combination W... http://bit.ly/kRPnkf
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Alicia C. Staley
CANCER SURVIVOR X3, Director of my own non-profit, chief survivor, getting my golf groove back.... POWER TWEETER and eternal optimist
Advertisement
